These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 139395)
1. Use of a spray to deliver drugs to the eye. Sharp J; Hanna C J Ark Med Soc; 1977 Apr; 73(11):462-3. PubMed ID: 139395 [No Abstract] [Full Text] [Related]
2. [New aspects on systemic adverse effects of ocular drugs]. Uusitalo H; Salminen L Duodecim; 1998; 114(3):287-92. PubMed ID: 10895504 [No Abstract] [Full Text] [Related]
3. [Current state and perspectives of further development of phonophoresis of drugs in ophthalmology (review of the literature)]. Marmur RK; Moiseeva NN; Korkhov SS Oftalmol Zh; 1979; 34(2):68-73. PubMed ID: 156900 [No Abstract] [Full Text] [Related]
4. A randomized comparison study of drop versus spray topical cycloplegic application. Goodman CR; Hunter DG; Repka MX Binocul Vis Strabismus Q; 1999; 14(2):107-10. PubMed ID: 10506687 [TBL] [Abstract][Full Text] [Related]
5. How drugs act. Drugs and the eye. Smith S Nurs Times; 1987 Jun 24-30; 83(25):48-50. PubMed ID: 3649734 [No Abstract] [Full Text] [Related]
6. Formulary of commonly used ophthalmologic medications. Zun LS; Mathews J Emerg Med Clin North Am; 1988 Feb; 6(1):121-6. PubMed ID: 3345712 [TBL] [Abstract][Full Text] [Related]
7. Nonhypotensive autonomic agents in veterinary ophthalmology. Klauss G; Constantinescu GM Vet Clin North Am Small Anim Pract; 2004 May; 34(3):777-800. PubMed ID: 15110984 [TBL] [Abstract][Full Text] [Related]
8. Autonomic drugs in ophthalmology: some problems and promises. Section II: Anticholinergic drugs. Holland MG Ann Ophthalmol; 1974 Jul; 6(7):661-4. PubMed ID: 4602195 [No Abstract] [Full Text] [Related]
9. Topical phenylephrine in laser in situ keratomileusis. Issa AF J Cataract Refract Surg; 2007 Feb; 33(2):355-6. PubMed ID: 17276291 [No Abstract] [Full Text] [Related]
10. [Variability in the effects of topical cycloplegics]. Esteban De Antonio M Arch Soc Esp Oftalmol; 2002 Jun; 77(6):299. PubMed ID: 12058286 [No Abstract] [Full Text] [Related]
15. [Topical drugs absorption in ocular surface diseases]. Durán de la Colina JA Arch Soc Esp Oftalmol; 2001 Aug; 76(8):457-8. PubMed ID: 11484138 [No Abstract] [Full Text] [Related]
16. [Apropos of the clinical use of the long-acting betamethasone preparation (celestone chronodose) in ophtalmology]. Faggioni R Schweiz Med Wochenschr; 1968 Jun; 98(26):976-9. PubMed ID: 5304126 [No Abstract] [Full Text] [Related]
17. [Neurological complications in topical administration of mydriatics]. Olivè Plana JM; Alonso-Villaverde C; González J; Borrás S Med Clin (Barc); 1991 Jun; 97(2):76-7. PubMed ID: 1895790 [No Abstract] [Full Text] [Related]
18. Ocular therapeutics. Jeglum EL Nurs Clin North Am; 1981; 16(3):453-77. PubMed ID: 6117832 [No Abstract] [Full Text] [Related]